Repatha (Amgen)
(https://repatha.com) 📸 Data Snapshot: June 19, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
There is a significant technical authority gap; despite being a major global drug, the schema_json is null across all pages, missing critical Organization or Product structured data. While ‘Cathy’ and ‘Jerry’ are cited as authorities of experience, they have no digital footprint or Person schema. The site lacks outbound links to the specific peer-reviewed studies mentioned, relying instead on internal text assertions.
The marketing tone uses bold assertions like ‘dramatically lower bad cholesterol,’ but unlike generic BS sites, Repatha actually backs this with specific numbers (84% of patients below 55 mg/dL). The disconnect is not in the truth of the claims, but in the lack of direct citations to ClinicalTrials.gov or published journals within the body text to verify the ’10 Years of Impact’ claim.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 0 |
| /what-is-repatha/ | 2 | 0 |
| /enrollment/ | 4 | 0 |
| /copaytcs/ | 3 | 0 |
This page presents a snapshot of public data from Repatha (Amgen), captured on June 19, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Repatha (Amgen): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://repatha.com to view the most current version of its content and see directly what this company is about and what it offers.